At least two bio tech firms are asking the FDA for permission to test CRISPR gene editing technology on humans as disease treatment, as early as this year.  And, it was only this past summer that CRISPR gene editing was first tried on live human human embryo cells in the U.S., none of which was ever intended for implantation.  But, the fast advancement of this medical technology has some concerned about a lack of standardized controls, especially in the area of so-called designer babies. Multiple parent surrogacy is already putting this issue front and center, and the rights of the children of these reproductive technologies is the subject of the book Babies of Technology.  Jane McMillan is joined by its author, Dr. Mary Ann Mason, UC Berkeley Professor.